Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 22, 2021

SELL
$216.38 - $257.67 $2.12 Million - $2.53 Million
-9,800 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $5,396 - $6,001
23 Added 0.24%
9,800 $2.49 Million
Q1 2018

Apr 11, 2018

BUY
$169.43 - $198.0 $1.66 Million - $1.94 Million
9,777 New
9,777 $1.67 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Divergent Wealth Advisors Portfolio

Follow Divergent Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Divergent Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Divergent Wealth Advisors with notifications on news.